FDA pulls emergency use authorization of hydroxychloroquine for COVID-19

By AHJ Staff June 17, 2020

The U.S. Food and Drug Administration recently rescinded its emergency use authorization for hydroxychloroquine to treat COVID-19. Based on new evidence, the agency said that the potential benefits of taking hydroxychloroquine and chloroquine to treat COVID-19 did not outweigh the risks (The New York Times).

AHJ Staff

American Healthcare Journal is healthcare’s No. 1 source for the latest insights, news and analysis. An authoritative, digital-first and editorially independent publication committed to providing decision makers with unparalleled thought leadership and objective, industry-focused information to help them run their businesses in the new era of healthcare.

Newsletter
Enter your email address to
subscribe to our newsletter.

Thank you for Signing Up
Please correct the marked field(s) below.
1,true,6,Subscriber Email,2
1,false,1,First Name,2
COVID-19 News
Featured Articles

July 10, 2020
McKinsey: ‘The Window To Act Is Now’ On Telehealth

The COVID-19 pandemic is increasing the use of telehealth in the United States, with 46 percent of consumers now preferring a telehealth visit over a traditional trip to a doctor’s office, according to a recent McKinsey & Company survey. In contrast, only 11 percent of patients preferred telehealth over office visits prior to the pandemic.

Read More

June 30, 2020
Three Ways Artificial Intelligence Is Changing Medicine

We may not be at the point where you overhear your surgeon saying, “Hey, Google, pass the scalpel,” but artificial intelligence (AI) is gradually making its way into the healthcare industry and, by extension, dermatology and plastic surgery practices. Even in its limited use, AI is already helping providers offer their patients better care, whether it’s preop, in the OR or during the recovery process.

Read More

June 12, 2020
Three Strategic Imperatives For Successful Office Reopenings

As a result of legal requirements driven by the novel coronavirus (COVID-19) pandemic, outpatient providers have seen an unprecedented drop in patient volume and demand for healthcare services since mid-March. Demand reduction has varied by specialty; however, most providers have experienced drops of at least 60 percent, with some as high as 100 percent. Now, as states begin to reopen, healthcare providers have a critical window to plan to capture as much pent-up demand as possible. It is yet to be seen how much of this demand will be “captured” versus “destroyed;” however, providers can take proactive steps now to optimize practice economics, cash positions and long-term practice strength.

Read More

FDA pulls emergency use authorization of hydroxychloroquine for COVID-19

Related Posts